Cryoport to report Q2FY26 results on August 6
Cryoport, Inc. will release its Q2 2026 financial results on August 6, 2026, followed by a conference call at 5:00 p.m. ET. The company will also publish a "Second Quarter 2026 in Review" document at 4:05 p.m. ET. Replays will be available online and via dial-in until August 13, 2026.

*this image is generated using AI for illustrative purposes only.
Cryoport, Inc., a global provider of integrated temperature-controlled supply chain solutions for the life sciences, will report its financial results for the second quarter ended June 30, 2026, on Thursday, August 6, 2026, after U.S. markets close. The announcement provides investors with an update on the company’s operational and financial performance for the period.
In addition to the earnings release, Cryoport will issue a document titled "Cryoport Second Quarter 2026 in Review" at 4:05 p.m. ET on the same day. This document offers a detailed review of financial and operational metrics and serves as a business update ahead of the management discussion.
Conference Call Details
Cryoport management will host a questions and answers conference call at 5:00 p.m. ET on August 6, 2026. The session will address inquiries from the investment community regarding the reported results, accompanied by a slide deck.
| Detail | Information |
|---|---|
| Date | Thursday, August 6, 2026 |
| Time | 5:00 p.m. ET |
| Dial-in (U.S.) | 1-800-717-1738 |
| Dial-in (Intl) | 1-646-307-1865 |
| Conference ID | 1142151 |
Investors are advised to allow 10 minutes prior to the call to download any necessary audio software. A live webcast will be available via the Investor Relations section of www.cryoportinc.com .
Replay Availability
The questions and answers call will be recorded and available approximately three hours after completion of the live event. The webcast replay will be accessible on the company’s website for a limited time. A dial-in replay will also be available until August 13, 2026. To access the dial-in replay, participants should call 1-844-512-2921 (United States) or 1-412-317-6671 (International) and enter the replay entry code: 1142151#.
About Cryoport, Inc.
Cryoport, Inc. (NASDAQ: CYRX) is headquartered in Nashville, Tennessee, with operations across the Americas, EMEA, and APAC. The company supports biopharmaceutical companies, contract manufacturers, and researchers with services including the Cryoportal Logistics Management Platform, advanced packaging, informatics, BioLogistics, biostorage, and cryopreservation services.
How will Cryoport's Q2 2026 results reflect the impact of recent expansions in its Cryoportal Logistics Management Platform on operational margins?
What specific growth drivers in the APAC and EMEA regions are management expected to highlight as key contributors to future revenue acceleration?
Will the earnings report indicate any shifts in customer demand patterns for biostorage and cryopreservation services amidst evolving biopharma R&D pipelines?

























